VelaVigo is a startup based in China. Brouky records 1 investor associated with the company.
VelaVigo is an antibody discovery company incubated by Panacea Venture and founded by Dr. Jing Li. It develops discovery platforms and programs for antibodies, including bi-specific and multi-specific constructs and antibody–drug conjugates across multiple therapeutic areas.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.